MedTrace Logo

Study About Contrast Media

NCT05678023 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-03-30

No results posted yet for this study

Summary

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Conditions

  • Small Bowel Obstruction

Interventions

OTHER

Effect on contrast media depending on the time of its administratsion

CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered

Sponsors & Collaborators

  • North Estonia Medical Centre

    collaborator OTHER

  • University of Tartu

    lead OTHER

Principal Investigators

  • Liis Jaanimäe · University of Tartu

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-03-30
Completion
2025-08-01

Countries

  • Estonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05678023 on ClinicalTrials.gov